
United States · Pharmaceuticals startup
Genexa is a clean medicine company founded in 2014 by David Johnson and Max Spielberg.
Funding reportedLast round: Series A
Genexa is a clean medicine company founded in 2014 by David Johnson and Max Spielberg.
The company aims to transform the medicine aisle by offering over-the-counter medicines that contain the same active ingredients as traditional options but without artificial fillers, dyes, or allergens. Genexa focuses on providing safe and effective products that align with family values, particularly for parents seeking cleaner alternatives for their children. The product range includes homeopathic and conventional formulations for pain, fever, cold, flu, and allergies. Notable offerings include Infants’ Acetaminophen Pain & Fever Oral Suspension and APAP for cold and flu symptoms. All products are free from artificial dyes, flavors, and preservatives, and are certified USDA Organic and Non-GMO Project Verified. Genexa primarily targets parents and health-conscious consumers, emphasizing transparency and ingredient quality. The company has also engaged healthcare providers and retailers through sampling programs and partnerships.
Funding, as reported
From Genexa's own website: 2 founders.
What they build
Known for
fever reducerartificial dye-freehealth caredye-freecertified gluten-freemedical advisory boardfamily wellnessallergy medicationconsumersdigestive healthnatural cold remediestransparent labelingactive ingredientsinactive ingredientsartificial preservative eliminationdisruptor
Built with from their website
Amazon Pay for BusinessMonetateGoogle Tag Managerparallax.jsKlaviyoFont AwesomeCloudFlareViewport MetaElement UIHubspot
Zendesk ChatFacebook SDKYotpoApple Business ManagerTwilio SendGrid Email Marketing CampaignsPriority HintsMicrosoft ExchangeApple Pay
Add your raise, your deck and your story, and put Genexa in front of investors. Or tell us what we have wrong.